Fine needle biopsy is the standard diagnostic test for indeterminate thyroid nodules, but increases medical costs and causes anxiety in patients. Researchers explored whether targeted use of Thyroid Imaging, Reporting, and Data System (TI-RADS) could provide faster and less-invasive diagnoses.
Bone density often decreases with age and is closely related to overall physical performance. Researchers studied whether the relationship between bone density and overall physical health extended to oral health as well.
Persistent subclinical hypothyroidism is linked to severe cardiovascular disease; monitoring thyroid levels may aid in identifying patients at risk.
Some studies have suggested there is an association between abnormalities seen on thyroid ultrasound and thyroid disease. Researchers in Seoul, South Korea sought to find a more definitive connection.
Decreased ovarian reserve and the number and quality of oocytes often occurs as the ovaries age and can cause fertility disorders and miscarriages. Researchers examined the relationship between thyroid-stimulating hormone levels and ovarian function.
Researchers conducted a systematic review and external validation study to assess the quality and accuracy of prognostic models for nephropathy and to validate these models in external cohorts of patients with type 2 diabetes.
People with type 2 diabetes are at an increased risk of several health complications, including heart failure. Researchers analyzed data from two large multinational trials to see if certain biomarkers could predict those at greatest risk for being hospitalized due to a serious cardiovascular event.
A possible relationship between homocysteine and C677T polymorphism in methylenetetrahydrofolate reductase (MTHFR) was investigated in a combined cross-sectional and longitudinal cohort study.
People diagnosed with type 2 diabetes can eventually achieve normal glucose levels. But whether or when this means a person is “in remission” was the subject of an international group of experts convened by the American Diabetes Association.
While calcitonin is considered standard of care for the diagnosis and follow-up of medullary thyroid cancer, researchers may have found a potentially more reliable marker.
